Starbucks is ending GLP-1 coverage for weight loss as employer costs climb
Starbucks will stop covering the GLP-1 drugs for weight loss, adding to a broader employer retreat from an increasingly costly benefit.
Starbucks will stop covering the GLP-1 drugs for weight loss, adding to a broader employer retreat from an increasingly costly benefit.
This article was originally published at: https://www.businessinsider.com/starbucks-cuts-glp-1-cove...